Furthermore, thalidomide has been shown to reduce the protein expression of angiopoietin-2 (ANGPT-2) and VEGF as well as to decrease mRNA expression of ANGPT-2 in patients with Crohn’s disease, a condition characterized by elevated levels of these proteins. Here, ANGPT2 is linked to Crohn disease.